Zymeworks (NYSE:ZYME) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.29) by 44.83 percent. This is a 13.51 percent decrease over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $10.030 million which missed the analyst consensus estimate of $17.431 million by 42.46 percent. This is a 71.81 percent decrease over sales of $35.578 million the same period last year.
Zymeworks Q1 2024 GAAP EPS $(0.42) Misses $(0.29) Estimate, Sales $10.030M Miss $17.431M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.